|
|
Volumn 9, Issue 5, 2000, Pages 417-422
|
|
Treatment with potentially hepatotoxic drugs and the risk of hepatocellular carcinoma: Results of a European case-control study
a
|
|
Author keywords
Case control study; Hepatocellular carcinoma; Hepatotoxic drugs
|
|
Indexed keywords
ALCOHOL;
ANTIHYPERTENSIVE AGENT;
ANTINEOPLASTIC AGENT;
AZATHIOPRINE;
BUFORMIN;
CHLORPROPAMIDE;
CLOFIBRATE;
CYCLOSPORIN A;
GLIBENCLAMIDE;
GLIBORNURIDE;
GLIPIZIDE;
GLIQUIDONE;
GLISOXEPIDE;
GLYMIDINE;
HEPATITIS B ANTIGEN;
HEPATITIS B CORE ANTIBODY;
HEPATITIS B SURFACE ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS C ANTIGEN;
IMMUNOSUPPRESSIVE AGENT;
METFORMIN;
METHOTREXATE;
METHYLDOPA;
MITOMYCIN;
NITROFURANTOIN;
ORAL ANTIDIABETIC AGENT;
ORAL CONTRACEPTIVE AGENT;
TOLBUTAMIDE;
ADOLESCENT;
ADULT;
AGE;
ALCOHOL ABUSE;
ARTICLE;
CANCER RISK;
CASE CONTROL STUDY;
CONTROLLED STUDY;
DRUG EXPOSURE;
EPIDEMIOLOGICAL DATA;
EUROPE;
FEMALE;
FREQUENCY ANALYSIS;
HEPATITIS B;
HEPATITIS C;
HIGH RISK PATIENT;
HUMAN;
LIVER CELL CARCINOMA;
LIVER TOXICITY;
LIVER TUMOR;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
PHARMACOEPIDEMIOLOGY;
PREVALENCE;
PRIORITY JOURNAL;
REGRESSION ANALYSIS;
RISK ASSESSMENT;
|
|
EID: 0033760368
PISSN: 10538569
EISSN: None
Source Type: Journal
DOI: 10.1002/1099-1557(200009/10)9:5<417::AID-PDS518>3.0.CO;2-H Document Type: Article |
|
Times cited : (1)
|
|
References (34)
|
